7Baggers
 arbutus: q3 earnings snapshot  New Haven Register Fri, 14 Nov 2025 05:42:57 GMT
 Arbutus: Q3 Earnings Snapshot  Greenwich Time Thu, 13 Nov 2025 19:49:05 GMT
 arbutus biopharma aktie: kampf um den durchbruch  kapitalmarktexperten.de Thu, 13 Nov 2025 16:32:14 GMT
 Arbutus Biopharma earnings missed, revenue fell short of estimates  Investing.com Thu, 13 Nov 2025 15:29:35 GMT
 arbutus biopharma reports q3 eps (4c), consensus (5c)  TipRanks Thu, 13 Nov 2025 14:15:06 GMT
 Arbutus Biopharma Faces Losses And Legal Battles This Quarter  Finimize Thu, 13 Nov 2025 14:05:39 GMT
 Arbutus (ABUS) Reports Q3 Results, Highlights Promising Imdusira  GuruFocus Thu, 13 Nov 2025 14:01:38 GMT
 Arbutus Biopharma Reports Strong Q3 Financial Results  TipRanks Thu, 13 Nov 2025 13:11:25 GMT
 Arbutus Biopharma Q3 revenue and net loss miss analyst estimates  MarketScreener Thu, 13 Nov 2025 12:45:14 GMT
 arbutus biopharma corp sec 10-q report  TradingView Thu, 13 Nov 2025 12:33:00 GMT
 can arbutus biopharma corporation stock continue upward trend  newser.com Tue, 04 Nov 2025 08:21:19 GMT
 published on: 2025-11-03 04:23:11  newser.com Mon, 03 Nov 2025 10:23:11 GMT
 why arbutus biopharma corporation (i9dn) stock stays undervalued  newser.com Sun, 02 Nov 2025 16:40:40 GMT
 can arbutus biopharma corporation stock continue upward trend  newser.com Thu, 30 Oct 2025 10:30:59 GMT

Arbutus Biopharma Corporation
(NASDAQ:ABUS) 

ABUS stock logo

Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-del...

Founded: 2007
Full Time Employees: 78
CEO: William Bill Collier  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends